Eurogentec SA

Eurogentec SA

Eurogentec SA

Overview
Date Founded

1985

Headquarters

LIEGE Science Park,5, rue du Bois Saint Jean,Seraing, Brussels Region 4102

Type of Company

Private

Industries

Biotechnology
Pharmaceuticals

Company Description

Eurogentec SA distributes reagents, kits and other related products for the biotechnology, pharmaceutical, and diagnostic sectors. It offers a range of services, from basic research in genomics and proteomics, to services associated with the development and manufacture of diagnostic and therapeutic products. The company was founded in 1985 and is headquartered in Seraing, Belgium.

Executives & Employees

Chief Finance Officer

Chairman & Chief Operating Officer

Chief Business Officer

Life Science Products & Services Director, Europe

Chemical Operations Director

Director-Biologics Business Unit

Director-Human Resources

Maintenance & Validation Manager

QC Manager

New Technologies Development Manager

Board of Directors

President at Eurogentec SA

Former Managing Director at Sofina SA

Executive Officer at Kaneka Corp.

Chief Business Officer at Eurogentec SA

Paths to Eurogentec SA
Potential Connections via
Relationship Science
You
Eurogentec SA
Recent Transactions
Details Hidden

Kaneka Corp. purchases Eurogentec SA from Matignon Investissement et Gestion SAS, Technowal SA, MEUSINVEST SA

Details Hidden

Matignon Investissement et Gestion SAS, Eurogentec SA, Technowal SA, MEUSINVEST SA purchase AnaSpec, Inc.

Details Hidden

Eurogentec SA purchases Epoch Biosciences, Inc. /Specialty Oligonucleotide Ops from Epoch Biosciences, Inc.

Transaction Advisors
Investment Advisor

Advised onKaneka Corp. purchases Eurogentec SA from Matignon Investissement et Gestion SAS, Technowal SA, MEUSINVEST SA

Legal Advisor

Advised onMatignon Investissement et Gestion SAS, Eurogentec SA, Technowal SA, MEUSINVEST SA purchase AnaSpec, Inc.

Legal Advisor

Advised onEurogentec SA purchases Epoch Biosciences, Inc. /Specialty Oligonucleotide Ops from Epoch Biosciences, Inc.

Investments
Details Hidden

Nippon Gene Material Co., Ltd. develops and manufactures custom-synthesized oligonucleotide. The company was founded in August 2001 and is headquartered in Toyama, Japan.

Details Hidden

Thymolux SA specializes in the provision of serum. It develops and produces thymoglobulin to prevent the phenomenon of rejections. The firm provides research and development services. The company was founded in 2008 and is headquartered in Marloie, Belgium.

Details Hidden

Probiox SA engages in the development and commercialization of solutions based on oxidative stress markers. The firm owns intellectual property related to the analysis and interpretation of oxidative stress parameters. It also provides turnkey solutions to companies for the evaluation of the antioxidant/anti-inflammatory properties of their products. The company's services include intellectual deliveries (literature reviews and scientific records for starting projects, registrations, claims, marketing support and scientific survey), clinical studies (assessment of oxidative stress in the context of existing studies or conducting turnkey studies) and In Vitro studies. Probiox was founded in 2001 and is headquartered in Liege, Belgium.

Investors
Details Hidden

MIG is an active private equity investment manager with a long-term outlook. Originally investing across a variety of industries, the firm has progressively focused on sectors including medical technology, healthcare-related services and biotechnology. They also invest in the information and communication technology sector, and their expansion financing and LBO activities are not sector-specific.MIG acquires significant minority stakes in French, European and US companies, balancing their investments across development stages. The firm targets companies based on a coherent commercial strategy and whose research efforts are mature. They seek board representation. Their exit strategies favor trade sales to large biomedical groups.MIG's specific interests within their sectors of expertise have included orthopedic implants for spinal surgery, nutritional counseling, biodegradable cardiovascular stents, surgical navigation systems, glucose measurement, sleep apnea and HIV non-progression.

Details Hidden

Technowal invests across sectors in companies based in Wallonia and in the Brussels region, except in sectors related to telecommunications, IT or the environment. The firm aims to foster the growth of companies developing innovative and exportable products.Technowal participates in expansion financing transactions as a co-investor and generally acquires minority stakes. The firm invests between EUR 250 thousand and 1.5 million in direct equity or subordinated debt in the form of obligation loans with warrants.

Details Hidden

Meusinvest is a regional private equity firm focused exclusively on the Liège region and its economic development. The firm invests growth capital in small- to medium-sized companies. They acquire minority interests and aim to pave the way for additional co-investment by banks and private investors. They invest primarily in the form of direct equity, which may be complemented with loans, leasings and bonds, convertible or not. Meusinvest seeks board representation and aims to coach their investee companies in terms of strategy, organization, business management and communication. They leverage an extensive network of partners, both public and private. They favor certain sectors and promote synergies between their portfolio companies.Meusinvest is a long-term investor. The firm stays invested in their portfolio companies for an undetermined period and exits through repurchase by the entrepreneur, at predetermined conditions. Their portfolio consists of a large number of participations in a wide variety of companies in the Liège area.